These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12749721)

  • 1. Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia).
    Staples MP; Giles GG; English DR; McCredie MR; Severi G; Cui JS; Hopper JL
    Cancer Causes Control; 2003 Mar; 14(2):161-6. PubMed ID: 12749721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era.
    Chen YC; Page JH; Chen R; Giovannucci E
    Prostate; 2008 Oct; 68(14):1582-91. PubMed ID: 18646000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives.
    Valeri A; Cormier L; Moineau MP; Cancel-Tassin G; Azzouzi R; Doucet L; Baschet F; Cussenot I; L'Her J; Berthon P; Mangin P; Cussenot O; Morin JF; Fournier G
    J Urol; 2002 Aug; 168(2):483-7. PubMed ID: 12131293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospective evaluation of prostate cancer screening in men with a family history of the disease].
    Paiss T; Herkommer K; Kahn D; Gschwend JE; Küfer R; Maier C; Vogel W; Högel J; Hautmann RE
    Urologe A; 2006 Aug; 45(8):1002-5. PubMed ID: 16830128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
    McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
    BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age at diagnosis and age at death in familial prostate cancer.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
    Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
    J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer risk prediction based on complete prostate cancer family history.
    Albright F; Stephenson RA; Agarwal N; Teerlink CC; Lowrance WT; Farnham JM; Albright LA
    Prostate; 2015 Mar; 75(4):390-8. PubMed ID: 25408531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
    Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
    Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer.
    Ellis WJ; Etzioni R; Vessella RL; Hu C; Goodman GE
    J Urol; 2001 Jul; 166(1):93-8; discussion 98-9. PubMed ID: 11435831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family history and prostate cancer screening with prostate-specific antigen.
    Mäkinen T; Tammela TL; Stenman UH; Määttänen L; Rannikko S; Aro J; Juusela H; Hakama M; Auvinen A
    J Clin Oncol; 2002 Jun; 20(11):2658-63. PubMed ID: 12039927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors.
    Spangler E; Zeigler-Johnson CM; Malkowicz SB; Wein AJ; Rebbeck TR
    Int J Cancer; 2005 Jan; 113(3):471-4. PubMed ID: 15455347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family history and prostate cancer risk.
    Lesko SM; Rosenberg L; Shapiro S
    Am J Epidemiol; 1996 Dec; 144(11):1041-7. PubMed ID: 8942435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer screening, changing age-specific incidence trends and implications on familial risk.
    Hemminki K; Rawal R; Bermejo JL
    Int J Cancer; 2005 Jan; 113(2):312-5. PubMed ID: 15386407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.
    Kiciński M; Vangronsveld J; Nawrot TS
    PLoS One; 2011; 6(10):e27130. PubMed ID: 22073129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial prostate cancer: a different disease?
    Kupelian PA; Klein EA; Witte JS; Kupelian VA; Suh JH
    J Urol; 1997 Dec; 158(6):2197-201. PubMed ID: 9366343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
    Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
    Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).
    Randazzo M; Müller A; Carlsson S; Eberli D; Huber A; Grobholz R; Manka L; Mortezavi A; Sulser T; Recker F; Kwiatkowski M
    BJU Int; 2016 Apr; 117(4):576-83. PubMed ID: 26332304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.